A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157Noah M. Hahn, Daniel M. Geynisman, Ashley E. Ross et al.|Clinical Cancer Research|2016Cited by 72